Lidoderm® (Lidocaine Patch 5%) in Diabetic and Idiopathic Neuropathy
Condition(s):DiabetesLast Updated:February 15, 2010Completed
Hide Studies Not Open or Pending
Condition(s):DiabetesLast Updated:February 15, 2010Completed
Condition(s):Postoperative Pain; Thyroid Diseases; Anesthesia, LocalLast Updated:November 28, 2023Recruiting
Condition(s):Cough; LidocaineLast Updated:July 2, 2020Unknown status
Condition(s):Aneurysm, CerebralLast Updated:November 12, 2020Unknown status
Condition(s):Hemodynamic Response; Acute Appendicitis; Complication of Treatment; Opioid Consumption; PneumoperitoneumLast Updated:October 31, 2023Completed
Condition(s):Hemodynamic ResponseLast Updated:August 24, 2011Completed
Condition(s):To Evaluate the Efficacy of Flushing the Uterine Cavity With Lidocaine Before Hysterosalpingo-Foam Sonography to Reduce Procedure-related PainLast Updated:July 28, 2020Unknown status
Condition(s):AnesthesiaLast Updated:December 29, 2017Completed
Condition(s):Pain, PostoperativeLast Updated:June 25, 2015Completed
Condition(s):Pain, Postoperative; Opioid UseLast Updated:January 31, 2023Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.